Meta-analysis: Vitamin D compounds in chronic kidney disease

Annals of Internal Medicine

Volumn 147, Issue 12, 2007, Pages 840-853

  Palmer, Suetonia C ^a   McGregor, David O ^b   Macaskill, Petra ^c   Craig, Jonathan C ^d   Elder, Grahame J ^e   Strippoli, Giovanni F M ^f  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; ALFACALCIDOL; CALCITRIOL; COLECALCIFEROL; DOXERCALCIFEROL; FALECALCITRIOL; PARATHYROID HORMONE; PARICALCITOL; PLACEBO; VITAMIN D; VITAMIN;

ALKALINE PHOSPHATASE BLOOD LEVEL; BLOOD VESSEL CALCIFICATION; BONE PAIN; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DEATH; DOSAGE SCHEDULE COMPARISON; DRUG EFFECT; DRUG EFFICACY; EVENING DOSAGE; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MEDLINE; META ANALYSIS; MINERAL METABOLISM; MORNING DOSAGE; OUTCOMES RESEARCH; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT; SYSTEMATIC REVIEW; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMINS;

EID: 38449117963     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-147-12-200712180-00004     Document Type: Review

References (118)